Skip to main content
Log in

Meta-analysis: RAAS inhibitors and COVID-19 positivity and/or mortality

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Usman MS, et al. A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19. American Journal of Cardiology : 2 Jun 2020. Available from: URL: http://doi.org/10.1016/j.amjcard.2020.05.038

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Meta-analysis: RAAS inhibitors and COVID-19 positivity and/or mortality. Reactions Weekly 1813, 7 (2020). https://doi.org/10.1007/s40278-020-80764-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-80764-1

Navigation